2017-08-23 20:26:21 UTC

Pfizer Accepting Applications for Visiting Professorship Program

Aug. 23, 2017

Up to $10,000 in funding available to organizations hosting IBD medical experts.

Pfizer’s Visiting Professorship Program will provide financial support for host organizations to coordinate education exchanges so that health-care practitioners, researchers and patients can benefit from the knowledge and on-site presence of distinguished medical experts who might otherwise be inaccessible. 

Funding is available for a broad range of areas including inflammatory bowel disease (IBD). In the U.S. the program is available to:

  • Accredited medical schools.
  • Medical centers with dedicated gastroenterology departments dedicated to IBD management and/or research.
  • Gastroenterology professional organizations that plan to host a visiting professor directly.

In Europe (including Israel, Turkey and Russia), Australia, New Zealand and Japan, the program is available to academic and non-academic hospitals responsible for the care of gastroenterology patients.

Priority will be given to plans that include robust opportunities for the visiting professor to interact with the health-care providers at the host organization beyond the lecture format.

For additional details, application requirements and submission requirements please visit http://www.pfizer.com/files/Pfizer_VisitingProfessorships_2017.pdf or contact IGLC@pfizer.com

The projects funded by Pfizer through the Pfizer Independent Grants for Learning & Change are the full responsibility of the recipient organization. Pfizer has no influence over any aspect of the projects and only asks for reports about the results and the impact of the projects in order to share them publicly.

More on IBD

Advancing Collaborative Approaches in IBD Treatment Decision-Making

March 14, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Advancing Collaborative Approaches in IBD Treatment Decision-Making

March 12, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Putting Patients First: Digital Health Tools to Empower IBD Patients

Jan. 18, 2018

Discover how advances in digital health can help you monitor and support IBD patients remotely and dynamically, improve face-to-face care, and drive clinical decisions through shared decision-making.